CS logo
small CS logo
Complejo Hospitalario de Cáceres

Caceres, Spain
General hospital in Spain
Av. de la Universidad, 75, 10004 Cáceres

About Complejo Hospitalario de Cáceres


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
PETHEMA Foundation
12
Medtronic Bakken Research Center
1
Stallergenes Greer
1
Total Rows: 3

Clinical Trials at Complejo Hospitalario de Cáceres


During the past decade, Complejo Hospitalario de Cáceres conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111111000011000000000000Started TrialsCompleted Trails20172018201920202021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rituximab Combined With Chemotherapy in Burkitt's Lymphoma
2006-08-01
2013-12-01
Completed
20
Treatment of Acute Myeloblastic Leukemia in Younger Patients
1999-01-01
2010-01-01
Completed
600
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
1996-06-01
2007-12-01
Completed
374
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
2007-07-01
2014-10-01
Completed
60
Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis
2009-01-01
2010-01-01
Completed
381
Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone
2011-02-01
2016-05-01
Completed
250
PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years
2010-05-01
2022-12-01
Recruiting
100
Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE
2008-01-01
2022-12-01
Recruiting
70

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario de Cáceres" #1 collaborator was "Celgene" with 2 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Adknoma" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Dynamic Science S.L." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPETHEMA Foundation: 12PETHEMA Foundation: 12Medtronic BakkenResearch Center: 1Medtronic BakkenResearch Center: 1Stallergenes Greer: 1Stallergenes Greer: 1

Created with Highcharts 11.1.0Top CollaboratorsCelgene: 2Celgene: 2MillenniumPharmaceuticals, Inc.: 2MillenniumPharmaceuticals, Inc.: 2Adknoma: 1Adknoma: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Dynamic Science S.L.: 1Dynamic Science S.L.: 1Janssen-Cilag Ltd.: 1Janssen-Cilag Ltd.: 1Sanofi: 1Sanofi: 1Start from scratch: 1Start from scratch: 1TFS Trial Form Support: 1TFS Trial Form Support: 1

Clinical Trials Conditions at Complejo Hospitalario de Cáceres


According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario de Cáceres" are "Acute Lymphoblastic Leukemia" (3 trials), "Multiple Myeloma" (3 trials), "Newly Diagnosed Multiple Myeloma" (2 trials), "Acute Lymphoblastic Leukemia Ph Positive" (1 trials) and "Acute Myeloblastic Leukemia" (1 trials). Many other conditions were trialed in "Complejo Hospitalario de Cáceres" in a lesser frequency.

Clinical Trials Intervention Types at Complejo Hospitalario de Cáceres


Most popular intervention types in "Complejo Hospitalario de Cáceres" are "Drug" (13 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (6 trials), "Prednisone" (3 trials), "Bortezomib" (2 trials), "Carfilzomib" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Complejo Hospitalario de Cáceres


The vast majority of trials in "Complejo Hospitalario de Cáceres" are 14 trials for "All" genders.

Clinical Trials Status at Complejo Hospitalario de Cáceres


Currently, there are NaN active trials in "Complejo Hospitalario de Cáceres". 1 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Complejo Hospitalario de Cáceres, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Complejo Hospitalario de Cáceres, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 4: 4Phase 4: 4Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Active, not recruiting: 3Active, not recruiting: 3Recruiting: 2Recruiting: 2Not yet recruiting: 1Not yet recruiting: 1Terminated: 1Terminated: 1